Decarboxy Moxifloxacin

Decarboxy Moxifloxacin (compound 8) is a decarboxylated compound of Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1].

Product Specifications

CAS Number

[1322062-57-6]

UNSPSC

12352005

Hazard Statement

H410

Target

Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Infection

Assay Protocol

https://www.medchemexpress.com/decarboxy-moxifloxacin.html

Purity

98.89

Solubility

DMSO : 10 mg/mL (ultrasonic)

Smiles

O=C1C=CN(C2CC2)C3=C1C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5)=C3OC

Molecular Formula

C20H24FN3O2

Molecular Weight

357.42

Precautions

H410

References & Citations

[1]Marks KR, et al. Synthesis and evaluation of 1-cyclopropyl-2-thioalkyl-8-methoxy fluoroquinolones.Bioorg Med Chem Lett. 2011 Aug 1;21 (15) :4585-8.|[2]Culley, C.M., et al., Moxifloxacin: clinical efficacy and safety. Am J Health Syst Pharm, 2001. 58 (5) : p. 379-88.